Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Salzman Insider Profile
4 Followers
Andrew Salzman, Chief Executive Officer at Kalytera Therapeutics, holds 3.93M shares in Kalytera Therapeutics (Ticker: KALTF).
Andrew Salzman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Salzman's holdings
Insider Roles
Chief Executive Officer
Roles that Andrew Salzman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew Salzman
Andrew Salzman's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Salzman's performance on stock
You May Also Like
Andrew Salzman insider profile FAQ
What is the percentage of profitable transactions made by Andrew Salzman?
The percentage of profitable transactions made by Andrew Salzman is ―.
What is the average return per transaction made by Andrew Salzman?
The average return per transaction made by Andrew Salzman is ―.
What stocks does Andrew Salzman hold?
Andrew Salzman holds: KALTF stocks.
What was Andrew Salzman’s latest transaction?
Andrew Salzman latest transaction was an Uninformative Buy of ―.
What was Andrew Salzman's most profitable transaction?
Andrew Salzman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew Salzman's role in Kalytera Therapeutics?
Andrew Salzman's role in Kalytera Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.